|
1
|
Functional 'immaturity' of isolated B cells from patients with hypogammaglobulinaemia.
|
Clin Exp Immunol
|
1980
|
1.45
|
|
2
|
Two immunologically distinct forms of late-onset hypogammaglobulinaemia.
|
Clin Exp Immunol
|
1981
|
1.27
|
|
3
|
Lymphocyte-stimulation tests and patch tests to carbamazepine hypersensitivity.
|
Clin Exp Immunol
|
1977
|
1.26
|
|
4
|
Cytomegalovirus-directed lymphocyte reactivity in healthy adults tested by a CMV-induced lymphocyte transformation test.
|
Clin Exp Immunol
|
1977
|
1.10
|
|
5
|
The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation.
|
Clin Exp Immunol
|
1985
|
1.07
|
|
6
|
Functional studies on T cells in adult human bone marrow.
|
Clin Exp Immunol
|
1979
|
1.05
|
|
7
|
The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen.
|
Clin Exp Immunol
|
1989
|
1.00
|
|
8
|
Suppression of DNA synthesis by Con A-activated human lymphocytes: Stimulation by con A bound to non-T cells unless removed after activation.
|
Clin Exp Immunol
|
1977
|
0.97
|
|
9
|
Human tonsil B lymphocyte function. I. The proliferative response to Staphylococcus aureus and pokeweed mitogen in relation to surface heavy chains mu and delta.
|
Clin Exp Immunol
|
1984
|
0.86
|
|
10
|
Reproducibility and clinical value of 18F-fluorodeoxyglucose positron emission tomography in recurrent melanoma.
|
Nucl Med Commun
|
2002
|
0.84
|
|
11
|
Efficacy of an anti-CD138 immunotoxin and doxorubicin on drug-resistant and drug-sensitive myeloma cells.
|
Int J Cancer
|
1999
|
0.83
|
|
12
|
T-lymphocyte number and function and the course of hepatitis B in hemodialysis patients.
|
Infect Immun
|
1976
|
0.83
|
|
13
|
Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma.
|
Blood
|
1989
|
0.81
|
|
14
|
Value of serum S-100B for prediction of distant relapse and survival in stage III B/C melanoma.
|
Anticancer Res
|
2008
|
0.80
|
|
15
|
Bispecific monoclonal antibody therapy of B-cell malignancy.
|
Leuk Lymphoma
|
1995
|
0.79
|
|
16
|
Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation.
|
Clin Exp Immunol
|
1992
|
0.79
|
|
17
|
Reversible hypogammaglobulinaemia after diphenylhydantoin and hydroxyzine therapy.
|
Neth J Med
|
1974
|
0.79
|
|
18
|
Human peripheral blood B cell subpopulations: surface IgD+ cells respond to pokeweed mitogen with plasma cell differentiation.
|
Clin Exp Immunol
|
1986
|
0.78
|
|
19
|
The value of immunohistochemistry and in situ hybridization in detecting cytomegalovirus in bone marrow transplant recipients.
|
APMIS
|
1990
|
0.78
|
|
20
|
Relation of cell-mediated immunity to staging, histology and prognosis in untreated patients with Hodgkin's disease.
|
Neth J Med
|
1976
|
0.78
|
|
21
|
Hodgkin's disease and herpes viruses.
|
Neth J Med
|
1976
|
0.77
|
|
22
|
Alloantigen-specific T-cell anergy induced by human keratinocytes is abrogated upon loss of cell-cell contact.
|
Immunology
|
1996
|
0.75
|
|
23
|
Cryosurgery in metastatic malignant melanoma.
|
Panminerva Med
|
1976
|
0.75
|
|
24
|
Extended continuous oral temozolomide in patients with progressive metastatic renal cell carcinoma not responding to interferon alpha 2b.
|
J Chemother
|
2005
|
0.75
|
|
25
|
Clonality in myelodysplastic syndromes.
|
Leuk Lymphoma
|
1994
|
0.75
|
|
26
|
Letter: Phagocytosis in chronic granulomatous disease.
|
Lancet
|
1975
|
0.75
|